Circulating permeability factors in the nephrotic syndrome: A fresh look at an old problem

Journal of the American Society of Nephrology

Volumn 14, Issue 2, 2003, Pages 541-543

  Glassock, Richard J ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; GLUCOCORTICOID; LYMPHOCYTE ACTIVATED VASCULAR PERMEABILITY FACTOR; PODOCIN; PROTEIN; UNCLASSIFIED DRUG;

EDITORIAL; FOCAL GLOMERULONEPHRITIS; GLOMERULUS FILTRATION; MINIMAL CHANGE GLOMERULONEPHRITIS; MOLECULAR BIOLOGY; NEPHROTIC SYNDROME; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEINURIA; T LYMPHOCYTE;

EID: 0037307462     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ASN.0000051640.04273.75     Document Type: Editorial

References (26)

1. Shaloub RJ: Pathogenesis of lipoid nephrosis: A disorder of T-Cell function. Lancet 2: 556-560, 1974
2. Brenchley PEC: Vascular permeability factors in steroid-sensitive nephrotic syndrome and focal segmental glomerulosclerosis. Nephrol Dial Transplant 2003, in press
3. Artero M, Biava C, Amend W, Tomlanovich S, Vincenti F: Recurrent focal glomerulosclerosis: Natural history and response to therapy. Am J Med 92: 375-383, 1992
4. Senggutuvan P, Cameron JS, Hartley RB, Rigden S, Chantler C, Haycock G, Williams DG, Ogg C, Koffman G: Recurrence of focal segmental glomerulosclerosis in transplanted kidneys: Analysis of incidence and risk factors in 59 allografts. Pediatr Nephrol 4: 21-28, 1990
5. Sharma RD, Sharma M, McCarthy ET, et al: Components of normal serum block the focal segmental glomerulosclerosis factor in vitro. Kidney Int 58: 1073-1079, 2000
6. Candiano G, Musante L, Carraro M, Faccini L, Campanacci L, Zennaro C, Artero M, Ginevri F, Perfumo F, Gusmano R, Ghiggeri GM: Apolipoproteins prevent glomerular albumin permeability induced in-vitro by serum from patients with focal segmental glomerulosclerosis. J Am Soc Nephrol 12: 143-150, 2001
7. Carraro M, Caridi G, Bruschi M, Artero M, Bertelli R, Zennaro C, Musante L, Candiano G, Perfumo F, Ghiggeri GM: Serum glomerular permeability activity in patients with podocin mutations (NPHS2) and steroid-reistant nephrotic syndrome. J Am Soc Nephrol 13: 1946-1952, 2002
8. Cattran D, Neogi T, Sharma R, McCarthy ET, Savin VJ: Serial estimates of serum permeability activity and clinical co-relates in patients with native kidney focal segmental glomerulosclerosis. J Am Soc Nephrol 14: 448-453, 2003
9. Savin VJ, Sharma R, Lovell HB, Welling DJ: Measurement of albumin reflection co-efficient with isolated rat glomeruli. J Am Soc Nephrol 3: 1260-1269, 1992
10. Savin VJ, Sharma R, Sharma M, McCarthy ET, Swan SK, Ellis E, Lovell H, Warady B, Gunwar S, Chonko AM, Artero M, Vincenti F: Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis. N Eng J Med 334: 878-883, 1996
11. Godfrin Y, Dantal J, Perretto S, Hristea D, Legendre C, Kreis H, Soulillou JP: Study of the in-vitro effect on glomerular albumin permselectivity of serum before and after renal transplantation in focal segmental glomerulosclerosis. Transplantation 64: 1711-1715, 1997
12. Feld SM, Figueroa P, Savin V, Nast CC, Sharma R, Sharma M, Hirschberg R, Adler SG: Plasmapheresis in the treatment of steroid-resistant focal segmental glomerulosclerosis in native kidneys. Am J Kidney Dis 32: 230-237, 1998
13. Musante L, Candiano G, Brusch M, Zennaro C, Carraro M, Artero M, Giuffrida MG, Conti A, Santucci A. Ghiggeri GM: Characterization of plasma factors that alter the permeability to albumin within isolated glomeruli. Proteomics 2: 197-205, 2002
14. Lagrue G, Branellec A, Blanc C, Xheneumont S, Beaudoux F, Sobel A, Weil B: A vascular permeability factor in lymphocyte culture supernatants from patients with nephrotic syndrome. II. Pharmacologic and physiochemical properties. Biomedicine 23: 73-75, 1975
15. Koyama A, Fujisaki M, Kobayashi M, Igarashi M, Narita M: A glomerular permeability factor produced bt human T-cell hybridomas. Kidney Int 40: 453-460, 1991
16. Bakker WW, Baller JF, van Luijk WH: A kallikrein-like molecule and plasma vasoactivity in minimal change disease. Increased turnover in relapse versus remission. Contrib Nephrol 67: 31-36, 1988
17. Cheung PK, Klok PA, Bakker WW: Minimal change like glomerular alterations induced by a human plasma factor. Nephron 74: 586-593, 1996
18. Cheung PK, Klok PA, Baller JF, Bakker WW: Induction of experimental proteinuria in vivo following infusion of human plasma hemopexin. Kidney Int 57: 1512-1520, 2000
19. Webb NJ, Watson CJ, Roberts IS, Bottomley MJ, Jones CA, Lewis MA, Postlethwaite RJ, Brenchley PE: Circulating vascular endothelial growth factor is not increased during relapses of the steroid sensitive nephrotic syndrome. Kidney Int 55: 1063-1071, 1999
20. Klanke B, Simon M, Rockl W, Weich HA, Stolte H, Grone HJ: Effects of vascular endothelial growth factor ((VEGF)/vascular permeability factor (VPF) on hemodynamics and permselectivity of isolated perfused rat kidney. Nephrol Dial Transplant 13: 875-885, 1998
21. Sewell RF, Brenchley PE, Mallick NP. Human mononuclear cells contain an endoglycosidase specific for haeparan sulfate glycosoaminoglycan demonstrable with the use of a specific solid phase metabolically radiolabelled substrate. Biochem J 264: 777-783, 1989
22. Dantal J, Godfrin Y, Koll R, Perretto S, Naulet J, Bouhours JF, Soulillou JP. Antihuman immunoglobulin affinity immunoadsorption decreases proteinuria in patients with relapsing nephrotic syndrome. J Am Soc Nephrol 9: 1709-1715, 1998
23. Dantal J, Bigot E, Bogers W, Testa A, Kriaa F, Jacques Y, Hurault de Ligny B, Niaudet P, Charpentier B, Soulillou JP.: Effect of plasma protein adsorption on protein excretion in kidney transplant recipients with recurrent nephrotic syndrome. New Engl J Med 330: 7-14, 1994
24. Sharma R, Savin VJ: Cyclosporin prevents the increase in glomerular albumin permeability caused by serum from patients with focal segmental glomerulosclerosis. Transplantation 61: 381-383, 1996
25. McCarthy ET, Sharma M: Indomethacin protects permeability barrier from focal segmental glomerulosclerosis serum. Kidney Int 61: 534-541, 2002
26. Trachtman H, Futterweit S, Singhal PC, Franki N, Sharma M, Sharma R, Savin V: Circulating factor in patients with recurrent focal segmental glomerulosclerosis postrenal transplantation inhibits expression of inducible nitric oxide synthase and nitric oxide production by cultured rat mesangial cells. J Investigative Med 47: 114-120, 1999